Prazitone

Prazitone
Clinical data
Other names	AGN-511; 5-Phenyl-5-(2-piperidylmethyl)barbituric acid
ATC code	none;
Identifiers
	IUPAC name 5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	2409-26-9 ;
PubChem CID	3050417;
ChemSpider	2312482 ;
UNII	6DZB018428;
CompTox Dashboard (EPA)	DTXSID80862926 ;
Chemical and physical data
Formula	C16H19N3O3
Molar mass	301.346 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CCNC(C1)CC2(C(=O)NC(=O)NC2=O)C3=CC=CC=C3;
	InChI InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22) ; Key:UGZAKKMLMJITLL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Prazitone (INNTooltip International Nonproprietary Name, BANTooltip British Approved Name; developmental code name AGN-511) is a barbiturate derivative described as an antidepressant which was developed in the 1960s.^[1]^[2] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.^[3]^[1] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.^{[citation needed]}

Quick facts Clinical data, Other names ...

[1]

[2]

[3]

Prazitone

References

Wikiwand - on